GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Esgen Acquisition Corp (NAS:ESAC) » Definitions » Cash, Cash Equivalents, Marketable Securities

Esgen Acquisition (Esgen Acquisition) Cash, Cash Equivalents, Marketable Securities : $0.27 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Esgen Acquisition Cash, Cash Equivalents, Marketable Securities?

Esgen Acquisition's quarterly cash, cash equivalents, marketable securities stayed the same from Mar. 2023 ($0.05 Mil) to Jun. 2023 ($0.05 Mil) but then increased from Jun. 2023 ($0.05 Mil) to Sep. 2023 ($0.27 Mil).

Esgen Acquisition's annual cash, cash equivalents, marketable securities increased from . 20 ($0.00 Mil) to Dec. 2021 ($1.32 Mil) but then declined from Dec. 2021 ($1.32 Mil) to Dec. 2022 ($0.62 Mil).


Esgen Acquisition Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Esgen Acquisition's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Esgen Acquisition Cash, Cash Equivalents, Marketable Securities Chart

Esgen Acquisition Annual Data
Trend Dec21 Dec22
Cash, Cash Equivalents, Marketable Securities
1.32 0.62

Esgen Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.62 0.05 0.05 0.27

Esgen Acquisition Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Esgen Acquisition  (NAS:ESAC) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Esgen Acquisition Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Esgen Acquisition's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Esgen Acquisition (Esgen Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
5956 Sherry Lane, Suite 1400, Dallas, TX, USA, 75225
Website
Esgen Acquisition Corp is a blank check company.
Executives
Larry L Helm director 1000 LOUISIANA, SUITE 5600, HOUSTON TX 77002
James P. Benson director 5956 SHERRY LANE, SUITE 900, DALLAS TX 75225
Mark M Jacobs director 1111 LOUISIANA STREET, HOUSTON TX 77002
Andrea Bernatova director, officer: CEO and Director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Esgen Llc 10 percent owner 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Nader Daylami officer: Chief Financial Officer 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Michael C Mayon director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225
Sanjay Bishnoi director 5956 SHERRY LANE, SUITE 1400, DALLAS TX 75225